NeuroPace Inc (NPCE) stock
NPCENasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/3028% above fair value
$8.22+0.02 (+0.24%)
Close on Nov 18, 2026Market cap $282.15MP/E –Yield 0.00%
NeuroPace net income
Net income is the profit left for shareholders after every expense, interest and tax.
NeuroPace's net income for the twelve months ending Jun 30, 2026 was -$19.11M. For fiscal 2025 it was -$21.47M. The highest annual figure on record is -$21.47M in fiscal 2025.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$21.47M | – |
| FY2024 | Dec 31, 2024 | -$27.14M | – |
| FY2023 | Dec 31, 2023 | -$32.96M | – |
| FY2022 | Dec 31, 2022 | -$47.08M | – |
| FY2021 | Dec 31, 2021 | -$36.08M | – |
| FY2020 | Dec 31, 2020 | -$24.28M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$6.20M | – |
| Q1 FY2026 | Mar 31, 2026 | -$6.69M | – |
| Q4 FY2025 | Dec 31, 2025 | -$2.73M | – |
| Q3 FY2025 | Sep 30, 2025 | -$3.50M | – |
| Q2 FY2025 | Jun 30, 2025 | -$8.65M | – |
| Q1 FY2025 | Mar 31, 2025 | -$6.59M | – |
| Q4 FY2024 | Dec 31, 2024 | -$5.25M | – |
| Q3 FY2024 | Sep 30, 2024 | -$5.45M | – |
| Q2 FY2024 | Jun 30, 2024 | -$7.51M | – |
| Q1 FY2024 | Mar 31, 2024 | -$8.93M | – |
| Q4 FY2023 | Dec 31, 2023 | -$6.20M | – |
| Q3 FY2023 | Sep 30, 2023 | -$7.26M | – |
| Q2 FY2023 | Jun 30, 2023 | -$9.12M | – |
| Q1 FY2023 | Mar 31, 2023 | -$10.38M | – |
| Q4 FY2022 | Dec 31, 2022 | -$11.15M | – |
| Q3 FY2022 | Sep 30, 2022 | -$11.79M | – |
| Q2 FY2022 | Jun 30, 2022 | -$12.69M | – |
| Q1 FY2022 | Mar 31, 2022 | -$11.46M | – |
| Q4 FY2021 | Dec 31, 2021 | -$10.69M | – |
| Q3 FY2021 | Sep 30, 2021 | -$8.08M | – |
| Q2 FY2021 | Jun 30, 2021 | -$8.49M | – |
| Q1 FY2021 | Mar 31, 2021 | -$8.81M | – |
| Q4 FY2020 | Dec 31, 2020 | -$4.62M | – |
| Q3 FY2020 | Sep 30, 2020 | -$4.13M | – |
| Q2 FY2020 | Jun 30, 2020 | -$8.79M | – |
| Q1 FY2020 | Mar 31, 2020 | -$6.74M | – |
See a number that looks wrong?